Trial intelligence / Profile preview

Allopurinol in Advanced Chronic Heart Failure

NCT00997542Phase 4Completed

Sponsor
National Heart and Lung Institute
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in chronic heart failure (CHF) comparing Allopurinol Sequence with Placebo Sequence (2 arms). Primary endpoint: Postischemic peak peripheral blood flow. Status: completed.

02

Drugs

allopurinol
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on NCT00997542.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00997542.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call